In colorectal cancer (CRC), CXCL13 was detected in both T cells and tumor cells, and CXCL13 deletion characterized with fewer infiltrating TFH and B cells was associated with a higher recurrence rate and poorer survival [50]. The gene discussed is CXCL13; the disease is neoplasm.